Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region Tumors
Zhaoyun Zhang · Craniopharyngiomas · Pituitary Macroadenoma
Phase 4
Enrolling by invitation
152
2026-07
A source-linked view of every Desmopressin study in the current snapshot—status, phase, enrollment, results, publications, locations and changes over time.
Largest indexed study
1,099,551 participants · NCT04740645 →Developer / research origin
Multiple
Evidence summary
Desmopressin appears in 75 indexed studies: 8 recruiting, 39 completed and 7 with registry results posted. The highest registered development stage in this snapshot is Phase 4. These counts measure registry activity; they do not establish that Desmopressin is safe or effective.
Review the design, endpoints, population, protocol changes, statistical analysis and publications before drawing conclusions.
Current studies
Completed studies
Stopped studies
Zhaoyun Zhang · Craniopharyngiomas · Pituitary Macroadenoma
Phase 4
Enrolling by invitation
152
2026-07
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Cushing Syndrome
Phase 2
Recruiting
140
2026-07
Hamilton Health Sciences Corporation · Chronic Kidney Diseases · Acute Kidney Injury
Phase 3
Recruiting
100
2026-05
Rochester General Hospital · Hyponatremia Symptomatic · Osmotic Demyelination Syndrome
Not applicable
Enrolling by invitation
800
2026-05
National Institute of Neurological Disorders and Stroke (NINDS) · Cushing's Disease · Pituitary Adenoma
Not applicable
Recruiting
22
2026-04
Mansoura University · Nocturnal Enuresis in Children
Phase 3
Recruiting
120
2025-09
Ain Shams University · Nocturnal Enuresis · Vitamin D Deficiency
Not applicable
Completed
90
2026-03
Menoufia University · Nocturnal Enuresis in Children · Desmopressin
Not applicable
Completed
398
2026-01
Ferring Pharmaceuticals · Adverse Drug Event
Not applicable
Completed
1,099,551
2025-12
University Hospital, Basel, Switzerland · SIAD - Syndrome of Inappropriate Antidiuresis · Hyponatremia
Not applicable
Completed
15
2025-03
Nxera Pharma UK Limited · Healthy
Phase 1
Completed
42
2025-02
Menoufia University · Enuresis, Nocturnal
Not applicable
Completed
90
2025-01
Montefiore Medical Center · Nocturnal Enuresis · Anemia, Sickle Cell
Phase 4
Terminated
8
2024-05
University Hospitals Cleveland Medical Center · Postoperative Ecchymosis
Phase 2
Terminated
14
2023-08
Montefiore Medical Center · Nocturnal Enuresis · Anemia, Sickle Cell
Not applicable
Terminated
14
2022-05
Ferring Pharmaceuticals · Nocturia
Not applicable
Terminated
835
2021-02
University of Kansas Medical Center · Kidney Damage
Phase 4
Withdrawn
0
2019-05
Cardiochirurgia E.H. · Bleeding · Blood Transfusion
Not applicable
Terminated
200
2018-01
Full study index
Add status, phase, condition, country, result and publication filters inside this molecule’s indexed study set.
75 matching studies
Last registry update first
Latest publications
Related pages
Commercial research listings, where present, are kept separate from clinical evidence and are not treatment recommendations.